# US 2013/0156825 A1 · Modafinil Formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156825 A1
- Document ID: US20130156825A1
- Status: Published application
- Kind: A1
- Application number: 13/773,016
- Filed: 2013-02-21
- Published: 2013-06-20
- Earliest claimed: 2002-11-26
- Assignees: Cephalon, Inc.
- Inventors: Moshe Bentolila; Aldo Shusterman; Moshe Arkin; Joseph Kaspi
- Web page: https://patentgrep.com/patent/US20130156825A1

## CPC

- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 9/1635: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/2077: {Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets}
- A61P 25/00: Drugs for disorders of the nervous system
- Y10T 428/2982: Particulate matter [e.g., sphere, flake, etc.]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The invention provides an oral pharmaceutical composition comprising modafinil particles, wherein at least about 5% of said modafinil particles have a diameter greater than 200 microns.

## Claims

### Claim 1

An oral pharmaceutical composition comprising modafinil particles, wherein at least about 15% of the cumulative total of said modafinil particles have a diameter of more than about 200 microns and more than about 5% of the cumulative total of said modafinil particles have a diameter of more than about 250 microns.

### Claim 2 (depends on 1)

The pharmaceutical composition of claim 1, wherein the median of the cumulative total of modafinil particles is greater than 60 microns.

### Claim 3 (depends on 2)

The pharmaceutical composition of claim 2, wherein the median of the cumulative total of modafinil particles is greater than about 80 microns.

### Claim 4 (depends on 1)

The pharmaceutical composition of claim 1, wherein the composition comprises 100 milligrams of said modafinil.

### Claim 5 (depends on 1)

The pharmaceutical composition of claim 1, wherein said composition comprises about 200 milligrams of said modafinil.

### Claim 6 (depends on 1)

The pharmaceutical composition of claim 1, wherein said composition has a dissolution rate in 0.1 N HCl at 37° C. of more than 80% in 30 minutes.

### Claim 7 (depends on 1)

The pharmaceutical composition of claim 1, wherein said composition additionally comprises colloidal silicon dioxide, crospovidone, lactose, talc, sodium stearyl fumarate and povidone.
